A detailed history of California State Teachers Retirement System transactions in Altimmune, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 66,964 shares of ALT stock, worth $602,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,964
Previous 69,409 3.52%
Holding current value
$602,676
Previous $461,000 10.85%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.5 - $8.1 $13,447 - $19,804
-2,445 Reduced 3.52%
66,964 $411,000
Q2 2024

Aug 14, 2024

BUY
$5.91 - $10.23 $92,662 - $160,396
15,679 Added 29.18%
69,409 $461,000
Q1 2024

May 15, 2024

BUY
$8.22 - $13.81 $370,163 - $621,891
45,032 Added 517.73%
53,730 $546,000
Q4 2023

Feb 13, 2024

SELL
$2.14 - $11.62 $4,727 - $25,668
-2,209 Reduced 20.25%
8,698 $97,000
Q3 2023

Nov 14, 2023

SELL
$2.4 - $3.45 $13,286 - $19,099
-5,536 Reduced 33.67%
10,907 $28,000
Q2 2023

Aug 21, 2023

SELL
$3.45 - $5.97 $91,990 - $159,184
-26,664 Reduced 61.86%
16,443 $58,000
Q1 2023

May 09, 2023

BUY
$4.19 - $16.83 $2,191 - $8,802
523 Added 1.23%
43,107 $181,000
Q4 2022

Feb 14, 2023

BUY
$8.74 - $16.45 $372,184 - $700,506
42,584 New
42,584 $700,000
Q2 2022

Aug 15, 2022

SELL
$3.94 - $11.77 $66,755 - $199,419
-16,943 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.9 - $9.45 $26,402 - $42,288
-4,475 Reduced 20.89%
16,943 $103,000
Q3 2021

Nov 15, 2021

SELL
$8.43 - $16.81 $197,422 - $393,673
-23,419 Reduced 52.23%
21,418 $242,000
Q2 2021

Aug 16, 2021

BUY
$9.85 - $16.46 $441,644 - $738,017
44,837 New
44,837 $442,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $441M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.